Evidence map›Paper›PMID 41616239›Full record

ArticleJCO clinical cancer informatics2026

Novel R Shiny Tool for Survival Analysis With Time-Varying Covariate in Oncology Studies: Overcoming Biases and Enhancing Collaboration.

Yimei Li, Yang Qiao, Fei Gao, Jordan Gauthier, Qiang Ed Zhang, Jenna Voutsinas, Wendy Leisenring, Ted Gooley, Corinne Summers, Alexandre Hirayama and 4 more

Erratum issuedAbstract read
In one paragraph

Article in JCO clinical cancer informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Yimei LiDepartment of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA.ORCID 0000-0001-9067-6992
Yang QiaoDepartment of Statistics, Iowa State University, Amers, IA.ORCID 0000-0002-6534-5304
Fei GaoVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0001-6797-5468
Jordan GauthierClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0002-5769-8409
Qiang Ed ZhangWills Eye Hospital, Thomas Jefferson University, Philadelphia, PA.
Jenna VoutsinasClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
Wendy LeisenringClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0001-7405-0906
Ted GooleyClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
Corinne SummersClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
Alexandre HirayamaClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0001-7980-3882
Cameron J TurtleThe University of Sydney, Camperdown, NSW, Australia.
Rebecca GardnerSeattle Children's, Seattle, WA.ORCID 0000-0003-1532-3200
Jarcy ZeeDepartment of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA.
Qian Vicky WuClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0002-2292-4816

Funding

Prospective evaluation of barriers to patient referral and enrollment in emerging cellular therapy trials: determining methods and structure to improve equity in future trial designU01TR002487 · NCATS · SEATTLE CHILDREN'S HOSPITAL · PI PARK, JULIE R, RAMSEY, BONNIE W · 2018 to 2022
$7.2M
NCATS NIH HHS U01 TR002487
6 · The paper itself

Abstract

purposeOur study is motivated by evaluating the role of hematopoietic cell transplantation (HCT) after chimeric antigen receptor T-cell (CAR-T) therapy for ALL, a debated topic. Because patients may receive HCT at different times after CAR-T infusion or never, HCT post-CAR-T should be considered as a time-varying covariate (TVC).

methodsStandard Cox models and Kaplan-Meier (KM) curves (naïve method) assume that TVC status is known and fixed at baseline, which can yield biased estimates. Landmark analysis is a popular alternative but depends on a chosen landmark time. Time-dependent (TD) Cox model is better suited for TVC although visualizing survival curves is complex. The newly proposed Smith-Zee method generates appropriate survival curves from TD Cox models.

resultsTo address these challenges, we developed an open-source R Shiny tool integrating multiple models (naïve Cox, landmark Cox, and TD Cox) and curves (naïve KM, landmark KM, Smith-Zee, and Extended KM) to facilitate TVC analysis. Reanalysis of post-CAR-T HCT's effect on leukemia-free survival (LFS) showed consistent results between naïve and TD Cox models, whereas landmark analyses varied by landmark time. A separate data analysis of chronic graft-versus-host disease and survival showed that substantial differences emerged across statistical methods. Simulations revealed increased bias in naïve methods when TVC changed late and minimal bias when TVC changes occurred early relative to time to events.

conclusionWe recommend TD Cox models and Smith-Zee curves for robust TVC analysis. Our R Shiny tool supports standardized analyses without requiring data sharing, thereby promoting collaboration across different institutions and providing a practical tool to advance survival analysis in oncology research.

Indexed as

Medical OncologySoftwareHematopoietic Stem Cell TransplantationHumansImmunotherapy, AdoptiveKaplan-Meier EstimateProportional Hazards ModelsSurvival Analysis

Identifiers

PMID41616239
PMCPMC12885575

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.